Multi-Cancer Early Detection Test
Finding cancer early enough to make a difference.
The Galleri® Multi-Cancer Early Detection (MCED) test is a new cancer screening test that can detect a shared cancer signal across 50 types of cancer through a simple blood sample. The new MCED test screens for types of cancers that currently have no recommended screening tests. It can also alert you to hard-to-detect, aggressive, and often fatal types of cancer like pancreatic, ovarian, and esophageal cancers.
The MCED test, which should be used together with U.S. guideline-recommended annual cancer screenings, looks for signals in the bloodstream that may be linked to cancer. If a cancer signal is detected, the test can often pinpoint its origin in the body to help the care team develop the next steps for treatment or additional diagnostic testing.
Ready to learn more? Read on below or watch the video all about “What is Galleri?”
Key Benefits of the Galleri Test
Early Cancer Detection
Looks for a cancer signal present in the blood that may indicate cancer, to allow for earlier treatment.
Completed with a simple blood draw at your provider's office, with results in about two weeks.
If a cancer signal is found, the results predict where in the body the cancer may be located.
WHO CAN BENEFIT FROM THE TEST?
Memorial Health is providing access to the Galleri test to patients who meet the eligibility requirements:
- An established patient of a Memorial Medical Group primary/specialty care practice
- Must reside in the United States
- Age 50 years or older
- Not currently pregnant
- Not currently undergoing active cancer treatment
Is a person eligible if younger than 50 years old?
Please discuss with your provider – they will review your medical history and risk factors, and determine if you are eligible for the test.
Is a person with history of cancer eligible?
Yes, as long as you are not currently in active cancer treatment and have completed cancer treatment at least 5 years ago*.
*Excludes basal or squamous cell carcinoma of the skin.
WHAT IS THE TESTING PROCESS?
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. It is intended to be used in addition to and not replace other cancer screening tests your healthcare provider recommends.
First step, talk to your healthcare provider at Memorial about your risk for cancer, and whether the Galleri test is right for you.
If your provider determines the Galleri test is appropriate for you, a simple blood draw will be completed at the office (no preparation or fasting is required) and your doctor will provide details on what the test may tell you.
From there, your provider will reach out when your results are ready – about two weeks after your blood draw. They will share and discuss your results, as well as coordinate any follow-up care if needed.
Insurance does not typically cover the test at this time, but payment plans are available – ask your provider for more information.
HOW DOES THE GALLERI TEST WORK?
Through a simple blood draw, the Galleri multi-cancer early detection test detects a cancer signal shared by more than 50 types of cancer, many of which are not commonly screened for today.
The Galleri test does not detect all cancers and not all cancers may be detected in the blood.
The Galleri test looks for a signal present in the blood that may be associated with cancer at the time of your blood draw. If a cancer signal is detected, the results can point to where in the body the cancer signal is coming from to help your healthcare provider guide next steps.
There are two possible test results:
• No Cancer Signal Detected
No cancer signal was found. However, not all cancers can be detected by the Galleri test. Continue with all routine screening tests that your healthcare provider recommends. Missing routine cancer screenings or ignoring symptoms could lead to a delayed diagnosis of cancer.
• Cancer Signal Detected
There is a suspicion of cancer. The Galleri test predicts where in the body the cancer signal is coming from. The Galleri test does not diagnose cancer. Your healthcare provider will discuss appropriate follow-up testing to confirm if cancer is present.
False-positive test results do occur. This means that the test reported a cancer signal, but cancer was not found after additional testing. False-negative test results also occur. This means that the test did not detect a cancer signal, but cancer was confirmed to be present after additional testing.
Galleri cannot predict your risk of developing cancer in the future. You should continue to take other cancer screening tests your healthcare provider recommends. See Important Safety Information to the right.
IMPORTANT INFORMATION TO KNOW
- Through a blood draw, the Galleri test looks for active cancer and does not predict your future genetic risk for cancer.
- Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.
- The Galleri test does not detect all cancers and not all cancers can be detected in the blood.
- False positive and false negative results do occur.
- Galleri should be used in addition to screening tests your healthcare provider recommends.
Important Safety Information
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of “No Cancer Signal Detected” does not rule out cancer. A test result of “Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.READ MORE
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.